BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23718260)

  • 1. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
    Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
    Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
    Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
    Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients.
    Grzegorzewska AE; Mlot M; Leande M
    Adv Perit Dial; 2004; 20():185-9. PubMed ID: 15384823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
    Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
    Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
    Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
    Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysate interleukin-15 concentration and ultrafiltration capacity in patients undergoing peritoneal dialysis.
    Grzegorzewska AE; Mlot M
    Adv Perit Dial; 2003; 19():67-72. PubMed ID: 14763036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
    van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
    Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM; Morton AR; Iliescu EA
    Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients.
    Sawai A; Ito Y; Mizuno M; Suzuki Y; Toda S; Ito I; Hattori R; Matsukawa Y; Gotoh M; Takei Y; Yuzawa Y; Matsuo S
    Nephrol Dial Transplant; 2011 Jul; 26(7):2322-32. PubMed ID: 21098014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity of correcting cancer antigen 125 appearance rates by body surface area.
    Kawanishi H; Moriishi M; Harada Y; Sakikubo E; Nagai T; Tsuchiya S
    Adv Perit Dial; 2000; 16():22-5. PubMed ID: 11045255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
    J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.